Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Multiple Sclerosis Health Center

Font Size

2 Types of MS, Study Reveals

Blood Test Would Predict Success of Multiple Sclerosis Treatment
WebMD Health News
Reviewed by Laura J. Martin, MD

March 29, 2010 - New study findings may soon revolutionize multiple sclerosis (MS) treatment and diagnosis.

The study strongly suggests that there are two major types of MS and that a simple blood test can tell one from the other. By itself, that would be a major finding. But that's not all.

One type of MS responds to beta interferon, generally considered the best treatment. The other type does not -- and beta interferon treatment may even make it worse, find Stanford University researcher Lawrence Steinman, MD, and colleagues.

"I'm very excited about some of the implications of this," Steinman tells WebMD. "The most important implication is that a simple blood test could tell us who does and does not respond to beta interferon. It could be that about 25% of patients are in the 'do not benefit' group."

For patients who do respond to beta interferon, the study raises hopes that the drug may work better than previously thought. That's because the clinical trials that proved beta interferon to be effective likely enrolled both types of MS patients, watering down the drug's average efficacy in beta interferon responders.

In coming months, Steinman said, he hopes to show that the two kinds of MS respond differently to other MS drugs, too.

Patricia O'Looney, PhD, vice president for biomedical research at the National MS Society, said the study will help researchers solve some of the mysteries surrounding MS.

"No two people with MS are exactly alike in disease course and in response to therapy. Why is this?" O'Looney tells WebMD. "We don't understand why about 50% of people who take beta interferon don't respond well."

Two Routes to MS

Multiple sclerosis is an autoimmune disease caused by haywire immune responses that attack the myelin sheath protecting nerve fibers in the central nervous system. The culprits are lymphocytes called CD4 T helper cells, sometimes called the quarterbacks of the immune system.

In MS, a subset of CD4 cells called Th1 cells direct an inflammatory immune response against myelin. Beta interferon dampens this signal, so it's a great help to people with MS -- at least, to those who respond to treatment.

1 | 2 | 3

Today on WebMD

nerve damage
Learn how this disease affects the nervous system.
woman applying lotion
Ideas on how to boost your mood and self-esteem.
woman pondering
Get personalized treatment options.
man with hand over eye
Be on the lookout for these symptoms.
brain scan
worried woman
neural fiber
white blood cells
sunlight in hands
marijuana plant
muscle spasm